Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Chie Kudo"'
Autor:
Naoki Takahashi, Hirokazu Shoji, Kengo Nagashima, Hiroshi Imazeki, Narikazu Boku, Takeshi Kawakami, Kei Muro, Takeru Wakatsuki, Chie Kudo-Saito, Yukiya Narita, Kai Tsugaru, Yusuke Amanuma, Naohiro Okano, Yoshiyuki Yamamoto, Rika Kizawa, Kazunori Aoki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Gastric cancer (GC) is one of the most common and deadly malignant diseases worldwide. Despite revolutionary advances, the therapeutic efficacy of anti-PD1/PDL1 monoclonal antibodies in advanced GC is still low due to the emergence of inna
Externí odkaz:
https://doaj.org/article/d0862983d935473cb6e85adbf0ac9cc5
Autor:
Chie Kudo-Saito, Hiroshi Imazeki, Hiroki Ozawa, Hirofumi Kawakubo, Hidekazu Hirano, Narikazu Boku, Ken Kato, Hirokazu Shoji
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102075- (2024)
Peritoneal tumor dissemination and subsequent malignant tumor ascites (MTA) occur unexpectedly and repeatedly in patients with gastrointestinal (GI) cancers, and worsen quality of life and prognosis of the patients. Various treatments have been clini
Externí odkaz:
https://doaj.org/article/9a1d813fda324317aa1ac7ae97784b95
Autor:
Naoki Takahashi, Hirokazu Shoji, Kengo Nagashima, Hiroshi Imazeki, Narikazu Boku, Takeshi Kawakami, Kei Muro, Takeru Wakatsuki, Chie Kudo-Saito, Yukiya Narita, Kai Tsugaru, Yusuke Amanuma, Naohiro Okano, Yoshiyuki Yamamoto, Rika Kizawa, Kazunori Aoki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/907a904781714c80bf6d47dac396da55
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the clinical outcomes being extremely limited, blocking immune inhibitory checkpoint pathways has been in the spotlight as a promising strategy for treating gastrointestinal cancer. However, a distinct strategy for the successful treatment is
Externí odkaz:
https://doaj.org/article/a023ecd5d8b5432a89b86bae5a4fe430
Autor:
Hiroki Ozawa, Hiroshi Imazeki, Yamato Ogiwara, Hirofumi Kawakubo, Kazumasa Fukuda, Yuko Kitagawa, Chie Kudo-Saito
Publikováno v:
Translational Oncology, Vol 16, Iss , Pp 101307- (2022)
Intraperitoneal (i.p.) tumor dissemination and the consequent malignant ascites remain unpredictable and incurable in patients with gastrointestinal (GI) cancer, and practical advances in diagnosis and treatment are urgently needed in the clinical se
Externí odkaz:
https://doaj.org/article/9408442ff8034c37ab51cc228d57d32e
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Tumor metastasis is the major cause of death of colorectal cancer (CRC), and metastatic CRC remains incurable in many cases despite great advances in genetic and molecular profiling, and clinical development of numerous drugs, including im
Externí odkaz:
https://doaj.org/article/b438f505005e4a818848056e1e63d5f7
Autor:
Chie Kudo-Saito, Akiko Ishida, Yuji Shouya, Koji Teramoto, Tomoyuki Igarashi, Ryoko Kon, Kenji Saito, Chihiro Awada, Yamato Ogiwara, Masayoshi Toyoura
Publikováno v:
Cell Reports, Vol 24, Iss 7, Pp 1790-1801 (2018)
Summary: Immune dysfunction is a strong factor in the resistance of cancer to treatment. Blocking immune checkpoint pathways is a promising approach to improve anti-tumor immunity, but the clinical efficacies are still limited. We previously identifi
Externí odkaz:
https://doaj.org/article/c468e9ffb7fa47798110a7bad551eab1
Autor:
Narikazu Boku, Kazunori Aoki, Hirokazu Shoji, Hiroshi Imazeki, Takahiro Miyamoto, Chie Kudo-Saito
Figure S1: Gating strategy for flow cytometric analysis, Figure S2: IL33 knockdown in human cancer cells, Figure S3: Establishment of IL33 transfectants using human cancer cells, Figure S4: The roles of IL17RB+ ILC2s in the IL33+ tumor progression, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cea026e2a5efa37965347df14151f53
https://doi.org/10.1158/0008-5472.22423446
https://doi.org/10.1158/0008-5472.22423446
Autor:
Narikazu Boku, Kazunori Aoki, Hirokazu Shoji, Hiroshi Imazeki, Takahiro Miyamoto, Chie Kudo-Saito
Detailed methods to establish B16-F10 subclones and IL33 transfectants, and materials for RT-PCR, gene knockdown, and flow cytometry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2484a842b7e311c17f8d5dc40c30d038
https://doi.org/10.1158/0008-5472.22423443
https://doi.org/10.1158/0008-5472.22423443
Autor:
Narikazu Boku, Kazunori Aoki, Hirokazu Shoji, Hiroshi Imazeki, Takahiro Miyamoto, Chie Kudo-Saito
Recurrence and treatment resistance are major causes of cancer-associated death. There has been a growing interest in better understanding epithelial–mesenchymal transition, stemness of cancer cells, and exhaustion and dysfunction of the immune sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e28f6207f03ef85e6009fc43f0bfc8c
https://doi.org/10.1158/0008-5472.c.6511500.v1
https://doi.org/10.1158/0008-5472.c.6511500.v1